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ABSTRACT
Objectives: To investigate glucose regulation in young
adults with very low birth weight (VLBW; <1500 g) in
an Asian population.
Design: Cross-sectional observational study.
Setting: A general hospital in Hamamatsu, Japan.
Participants: 111 young adults (42 men and 69
women; aged 19e30 years) born with VLBW between
1980 and 1990. Participants underwent standard 75 g
oral glucose tolerance test (OGTT).
Primary and secondary outcome measures: The
primary outcomes were glucose and insulin levels
during OGTT and risk factors for a category of
hyperglycaemia deﬁned as follows: diabetes
mellitus, impaired glucose tolerance (IGT),
impaired fasting glycaemia (IFG) and non-diabetes/
IGT/IFG with elevated 1 h glucose levels
(>8.6 mmol/l). The secondary outcomes were
the pancreatic b cell function (insulinogenic
index and homeostasis model of assessment for beta
cell (HOMA-b)) and insulin resistance (homeostasis
model of assessment for insulin resistance
(HOMA-IR)).
Results: Of 111 young adults with VLBW, 21 subjects
(19%) had hyperglycaemia: one had type 2 diabetes,
six had IGT, one had IFG and 13 had non-diabetes/IGT/
IFG with elevated 1 h glucose levels. In logistic
regression analysis, male gender was an independent
risk factor associated with hyperglycaemia (OR 3.34,
95% CI 1.08 to 10.3, p¼0.036). Male subjects had
signiﬁcantly higher levels of glucose and lower levels
of insulin during OGTT than female subjects (p<0.001
for glucose and p¼0.005 for insulin by repeated
measures analysis of variance). Pancreatic b cell
function was lower in men (insulinogenic index:
p¼0.002; HOMA-b:p ¼0.001), although no gender
difference was found in insulin resistance (HOMA-IR:
p¼0.477). In male subjects, logistic regression
analysis showed that small for gestational age was an
independent risk factor associated with
hyperglycaemia (OR 33.3, 95% CI 1.67 to 662.6,
p¼0.022).
Conclusions: 19% of individuals with VLBW already
had hyperglycaemia in young adulthood, and male
ARTICLE SUMMARY
Article focus
- Neonatal intensive care has improved the
survival rate for very low birth weight infants
(VLBW; birth weight <1500 g) in recent decades,
and the ﬁrst generation of VLBW infants have
only recently reached young adulthood.
- Only a few studies have shown that VLBW (or
preterm) is associated with glucose intolerance
in Caucasian young adults, while glucose regu-
lation in Asian young adults with VLBW is still
uncertain.
- The present study investigated glucose regula-
tion in young adults with VLBW in an Asian
population and determined the factors associated
with hyperglycaemia.
Key messages
- Of 111 young adults with VLBW, 19% of
individuals already had hyperglycaemia (type 2
diabetes, impaired glucose tolerance (IGT),
impaired fasting glycaemia (IFG) and non-
diabetes/IGT/IFG with elevated 1 h glucose
levels).
- Male gender was a signiﬁcant independent risk
factor of hyperglycaemia in young adults with
VLBW.
- Small for gestational age was associated with
hyperglycaemia particularly in male young adults
with VLBW.
Strengths and limitations of this study
- This is the ﬁrst study assessing the glucose
regulation in young adults with VLBW in an Asian
population.
- This study does not provide information on
postnatal growth patterns, which have been
shown to be associated with later hypergly-
caemia in previous studies.
- The study design with no control subjects makes
it impossible to address the delayed impact of
VLBW itself on glucose regulation.
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Open Access Researchgender was a signiﬁcant independent risk factor of hyperglycaemia.
In male young adults with VLBW, small for gestational age was
associated with hyperglycaemia.
INTRODUCTION
In recent decades, progression of neonatal intensive care
has dramatically increased the survival rate of very low
birth weight (VLBW; birth weight <1500 g) infants
worldwide.
1 A lot of them have grown up into young
adults (now in their 20s or 30s). To date, epidemiolog-
ical studies have shown an association between low birth
weight and type 2 diabetes and cardiovascular disease in
later life.
2e4 Fetal malnutrition in the gestational period,
which prevents appropriate fetal growth in utero, is
thought to provoke thrifty phenotype in premature
babies. This phenotype is assumed to predispose them to
subsequent metabolic disorders. For this reason, to
foresee the later risk of type 2 diabetes is very crucial for
VLBW infants, which would lead to prevention of type 2
diabetes by early intervention in their lifestyle.
5e7
The ﬁrst generation of VLBW infants have only
recently reached young adulthood. A few studies have
shown that VLBW (or preterm) is associated with
glucose intolerance in young adulthood in Caucasian
populations,
8 9 while the glucose regulation in Asian
young adults with VLBW remains uncertain. To clarify
the characteristics of glucose metabolism in young adults
with VLBW in an Asian population, we investigated
glucose regulation in 111 young adults with VLBW by
performing detailed oral glucose tolerance test (OGTT),
which is useful for evaluation of early signs of glucose
intolerance.
METHODS
Study participants
The birth record database of Seirei Hamamatsu General
Hospital (Hamamatsu, Japan) showed that 628 subjects
were born with VLBW between 1980 and 1990 and were
treated at a neonatal intensive care unit (ﬁgure 1).
VLBW infants were deﬁned according to WHO criteria:
babies whose birth weight was <1500 g. Out of the 628
subjects, 229 were excluded because of death (n¼132)
or severe neurodevelopmental impairment (n¼97). To
the remaining 399 subjects, we sent letters that provided
information regarding the study and requested their
participation. Among the 399 letters, 98 were returned
marked as address unknown (ie, the remaining 301
letters were thought to reach their destinations).
Consequently, 111 subjects (aged 19e30 years) partici-
pated in the present study. All participants were Japa-
nese. Small for gestational age (SGA) status was
determined according to standards by a study group
of the Health Ministry in Japan: a birth weight below
the 10th percentile for gestational age.
10 The basal
characteristics of participants at birth are summarised in
table 1.
Measurements
All participants underwent a standard 75 g OGTT after
a 10 h overnight fast. Plasma glucose and serum insulin
concentrations were examined at 0, 30, 60, 90, 120 and
180 min during OGTT. Fasting glucose levels and 2 h
glucose levels were used for diagnosing diabetes
mellitus, impaired glucose tolerance (IGT) and
impaired fasting glycaemia (IFG) according to WHO
criteria.
11 Since it has been shown that 1 h plasma
glucose concentration is associated with future risk
of type 2 diabetes and atherosclerosis, 1 h plasma
glucose above 8.6 mmol/l (155 mg/dl) was included as
a category of hyperglycaemia.
12 13 Reactive hypo-
glycaemias during OGTT was deﬁned as the level of
plasma glucose <3.8 mmol/l, which causes the response
of counter-regulatory hormone release.
14
We measured plasma glucose and serum insulin levels
during OGTT with an autoanalyzer JCA-BM2250 (JEOL,
Tokyo, Japan). Plasma glucose was measured by means of
hexokinase method. The concentration of serum insulin
was measured with chemiluminescent enzyme immuno-
assay. Fasting blood samples were also drawn for other
measurements, total cholesterol, high-density lipopro-
tein cholesterol, low-density lipoprotein cholesterol,
triglyceride and creatinine. Glycated haemoglobin A1c
(HbA1c) was measured with high-performance liquid
chromatography method using an automated glyco-
haemoglobin analyser HLC-723G8 (Tosoh Bioscience,
Tokyo, Japan). The values for HbA1c were converted
from the Japanese Diabetes Society (JDS) values into the
National Glycohaemoglobin Standardization Program
(NGSP) equivalent values. The NGSP equivalent values
were calculated with the formula: HbA1c (%) ¼ JDS
value (%)+0.4.
15
Calculations and statistical analysis
Pancreatic b cell function was evaluated by both insuli-
nogenic index and homeostasis model of assessment for
beta cell (HOMA-b).
16 Insulinogenic index, the index of
early-phase insulin secretion, was calculated as the ratio
Figure 1 Flow of participants through the study.
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ment in glucose concentration ([30 min insulin (mU/ml)
e fasting insulin]/[30 min glucose (mg/dl)   fasting
glucose]). HOMA-b was calculated as follows: 20 3
fasting insulin (mU/ml)/[fasting glucose (mmol/l)  
3.5]. Insulin resistance was estimated by homeostasis
model of assessment for insulin resistance (HOMA-IR):
fasting insulin (mU/ml) 3 fasting glucose (mmol/l)/
22.5.
16 The total amounts of glucose and insulin levels
during OGTT were assessed by calculating areas under
the curve (AUC) with trapezoid rules. The estimated
glomerular ﬁltration rate (eGFR) was calculated
according to the following formula, as recommended
by the Japanese Society of Nephrology: eGFR (ml/
min/1.73 m
2)¼194 3 [Cre (mg/dl)]
 1.094 3 [Age
(years)]
 0.287 (30.739 if the subject is a woman).
17
Quantitative variables were expressed as mean and SD
or 95% CI; categorical variables were presented as
number and percentage. Differences between groups
were compared using the Student t test, the
ManneWhitney U test, the Pearson’s c
2 test or the
repeated measures analysis of variance (ANOVA) as
appropriate. The data on insulin levels during OGTT
were logarithmically transformed before the repeated
measures ANOVA. Logistic regression analysis, which
included gender, family history of diabetes within the
second degree, body mass index (BMI), gestational age,
birth weight and SGA/AGA (appropriate for gestational
age), was performed to estimate ORs for the category of
hyperglycaemia. For the further investigation into
glucose regulation, multiple linear regression analysis
was conducted. Gender, family history of diabetes, BMI,
gestational age, birth weight and SGA/AGA were
included in the model. The data on HOMA-b, HOMA-IR,
insulinogenic index and glucoseAUC were logarithmically
transformed before analysis to meet the assumptions of
normality. A p value of <0.05 was deﬁned as statistically
signiﬁcant. All analyses were conducted using SAS soft-
ware V.9.2 (SAS Institute) and the statistical software
R V.2.12.2 (http://www.r-project.org).
RESULTS
The basic characteristics of participants at study assess-
ment are shown in table 1. Of 111 young adults with
VLBW, 21 subjects (19%) had hyperglycaemia: one had
type 2 diabetes, six had IGT, one had IFG and 13 non-
diabetes/IGT/IFG subjects had elevated 1 h glucose
levels (>8.6 mmol/l). Hyperglycaemia was more
frequent in men than in women (26.2% for men vs
14.5% for women). In the logistic regression analysis
Table 1 Clinical characteristics of young adults with very low birth weight at birth and at study assessment
Total
(n[111)
Men (n[42) Women (n[69)
SGA*
(n[14)
AGA
(n[28)
SGA*
(n[25)
AGA
(n[44)
At birth
Gestational age (wk) 29.7 (3.1) 31.5 (3.7) 28.1 (1.9) 33.0 (2.6) 28.2 (1.9)
Weight (g) 1152 (235) 1050 (223) 1149 (235) 1190 (239) 1166 (236)
ELBW 33 (29.7) 6 (42.9) 10 (35.7) 7 (28.0) 10 (22.7)
Birth from multiple pregnancy 18 (16.2) 2 (14.3) 7 (25.0) 1 (4.0) 8 (18.2)
At study assessment
Age (yr) 24.8 (3.0) 24.9 (2.9) 24.6 (3.6) 23.9 (2.9) 25.4 (2.7)
Family history of diabetes 22 (19.8) 2 (14.3) 5 (17.9) 7 (28.0) 8 (18.2)
Height (m) 1.58 (0.07) 1.60 (0.06) 1.66 (0.06) 1.54 (0.06) 1.55 (0.05)
Body weight (kg) 52.3 (10.1) 53.1 (8.8) 55.8 (8.9) 47.5 (8.3) 52.4 (11.3)
BMI (kg/m
2) 20.9 (3.8) 20.8 (3.2) 20.3 (2.8) 20.1 (3.0) 21.7 (4.7)
Blood pressure (mm Hg)
Systolic 118 (16) 120 (18) 121 (17) 115 (12) 117 (16)
Diastolic 70 (11) 69 (15) 69 (11) 69 (11) 71 (11)
Cholesterol (mg/dl)
Total 184.8 (31.3) 210.6 (52.0) 183.4 (25.2) 180.4 (27.2) 179.9 (25.1)
LDL 104.3 (28.4) 126.9 (48.6) 104.8 (24.8) 100.3 (21.5) 99.0 (22.6)
HDL 65.7 (13.3) 63.2 (14.0) 64.6 (14.1) 64.6 (15.1) 67.8 (11.6)
Triglycerides (mg/dl) 81.8 (72.2) 126.5 (139.9) 81.0 (84.5) 85.4 (51.0) 65.9 (23.5)
Renal function
Creatinine (mg/dl) 0.66 (0.13) 0.76 (0.09) 0.80 (0.11) 0.59 (0.08) 0.58 (0.08)
eGFR (ml/min/1.73 m
2)y 104.6 (18.4) 105.5 (13.9) 101.8 (19.4) 104.3 (18.2) 106.3 (19.5)
*Determined by a birth weight below the 10th percentile for gestational age according to standards deﬁned by a study group of the Health
Ministry in Japan.
yCalculated according to the formula recommended by the Japanese Society of Nephrology: eGFR (ml/min/1.73 m
2)¼194 3 [Cre (mg/dl)]
 1.094
3 [Age (years)]
 0.287 (30.739 if the subject is a woman).
AGA, appropriate for gestational age; BMI, body mass index; eGFR, estimated glomerular ﬁltration rate; ELBW, extremely low birth weight
(<1000 g); HDL, high-density lipoprotein; LDL, low-density lipoprotein; SGA, small for gestational age.
Data are expressed as mean (SD) or number (%).
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degree, BMI, gestational age, birth weight and SGA/
AGA, male gender was a statistically signiﬁcant inde-
pendent factor associated with hyperglycaemia (OR 3.34,
95% CI 1.08 to 10.3, p¼0.036). BMI at study assessment
was also associated with hyperglycaemia (table 2).
Gender difference
As male gender was a signiﬁcant independent risk factor
of hyperglycaemia, we evaluated the differences in
glucose regulation between men and women in the
sample group. Figure 2 shows the glucose and insulin
response during OGTT in men and in women. Male
subjects had signiﬁcantly higher levels of glucose during
OGTT than female subjects (p<0.001 by repeated
measures ANOVA). In terms of insulin levels, male
subjects had lower levels of insulin during OGTT than
female subjects (p¼0.005 by repeated measures
ANOVA). GlucoseAUC during OGTT tended to be higher
in male subjects (table 3). As for the function of insulin
secretion, insulinogenic index and HOMA-b were
signiﬁcantly lower in men than in women. InsulinAUC
also showed a tendency to be lower in male subjects.
Reactive hypoglycaemias during OGTT tended to be
frequent in men. The differences in the mean values of
HbA1c and HOMA-IR were not statistically signiﬁcant.
There were no signiﬁcant gender differences in gesta-
tional age (p¼0.145), birth weight (p¼0.168), age at
study assessment (p¼0.845), BMI (p¼0.879), the
proportion of SGA (p¼0.756) and that of family history
of diabetes within the second degree (p¼0.516). The
variables for glucose metabolism in men and women are
summarised in table 3.
We evaluated the associations between gender and the
variables of glucose metabolism by multiple linear
regression analysis. Adjustments were made for family
history of diabetes within the second degree, BMI,
gestational age, birth weight and SGA/AGA. In this
analysis, male gender had inverse associations with
HOMA-b (b  0.336, 95% CI  0.509 to  0.163, p<0.001)
and insulinogenic index (b  0.195, 95% CI  0.344
to  0.047, p¼0.01). GlucoseAUC during OGTT tended to
be positively associated with male gender (b 0.056, 95%
CI  0.0047 to 0.116, p¼0.071).
In male subjects, after an adjustment for family history
of diabetes, BMI, gestational age and birth weight, the
logistic regression analysis showed that SGA was a statis-
tically signiﬁcant independent factor associated with
hyperglycaemia (OR 33.3, 95% CI 1.67 to 662.6,
p¼0.022).
DISCUSSION
To the best of our knowledge, this is the ﬁrst study
assessing the glucose regulation in young adults with
VLBW in an Asian population. Our study has indicated
that 19% of young adults with VLBW already had
hyperglycaemia: type 2 diabetes, IGT, IFG and non-dia-
betes/IGT/IFG with high 1 h plasma glucose level. A
report from the Japanese Ministry of Health, Welfare,
and Labour in 2007 showed that of 204 general young
adults (aged 20e29 years), two individuals (0.98%) had
high levels of HbA1c (>6.0%; NGSP equivalent
values),
18 while 3.6% of young adults with VLBW had the
HbA1c values >6.0% in the present study. In a previous
study, Hovi et al
9 reported that VLBW infants in young
adulthood had higher indexes of glucose intolerance
compared with term infants. A recent epidemiological
study has also shown that preterm birth is associated with
an increased risk of diabetes in young adults.
8 On the
other hand, a study in the Netherlands showed that
preterm birth was not associated with reduced insulin
sensitivity in young adulthood.
19 The ﬁndings of that
study may be biased by the way of recruiting the control
subjects born at term. Our ﬁndings would be in line with
the standpoint of high prevalence of hyperglycaemia in
premature infants in young adulthood, although
absence of control subjects presents a limitation of
demonstrating the impact of VLBW itself on glucose
regulation.
We have also found that male subjects had higher
glucose levels during OGTT than females. Previous
studies in the general population showed that women
had higher postload glucose levels than men, which were
explained by differences in body size.
20 21 During
Table 2 Correlated factors for hyperglycaemia* in young adults with very low birth weight assessed by logistic regression
analyses
Variable ORy (95% CI) p Value
Gender (male) 3.34 (1.08 to 10.3) 0.036
Factors at birth
Gestational age (wk) 0.77 (0.53 to 1.12) 0.165
Weight (0.1 kg) 1.39 (0.96 to 2.02) 0.085
SGA 2.56 (0.37 to 17.5) 0.340
Factors at study assessment
Family history of diabetes 1.92 (0.49 to 7.57) 0.353
BMI (kg/m
2) 1.29 (1.11 to 1.49) 0.001
*A category of hyperglycaemia includes diabetes, impaired glucose tolerance (IGT), impaired fasting glycaemia (IFG) and non-diabetes/IGT/
IFG with elevated 1 h glucose levels (>8.6 mmol/l).
yEach OR is calculated from a model including gender, family history of diabetes, BMI, gestational age, birth weight and SGA/AGA (appropriate
for gestational age).
BMI, body mass index; SGA, small for gestational age.
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amount of glucose, which is thought to be high dosage
for women relative to their body size. In our study,
however, men had signiﬁcantly higher levels of both
fasting and postload glucose concentrations during
OGTT. Moreover, male gender was associated with lower
b cell function and the risk of glucose intolerance. These
ﬁndings might indicate that men with VLBW are more
predisposed to diabetes than women; indeed, recent
studies have shown that male premature infants are
more vulnerable than females.
22e27 In particular, the
male sex is associated with various adverse outcomes
including death,
25 27 respiratory dysfunction,
22 intra-
ventricular haemorrhage,
24 autism spectrum
23 and
neurodevelopmental impairment.
26 Interestingly, in the
present study, the mean value of height (155 cm) in
women with VLBW is close to the average value of the
Japanese female population (158 cm), whereas men with
VLBW (164 cm) were found to be shorter compared
with the Japanese male population (171 cm) (average
height data of Japanese population were drawn from the
report by the Ministry of Education, Culture, Sports,
Science, and Technology in Japan).
28 In a previous study,
young adults who had been born SGA were shorter and
had higher glucose levels than those with a normal birth
weight.
29 Reduced ﬁnal height might be long-term
consequences of intrauterine retardation, which would
also inﬂuence glucose regulation. Further investigation
is needed to clarify whether the inﬂuence of VLBW on
physical growth is more remarkable in male than in
female infants and elucidate the relationship between
physical growth and glucose regulation.
Previous studies have shown that SGA itself is associ-
ated with glucose intolerance.
30 In our study, SGA was
not signiﬁcantly associated with hyperglycaemia in total
subjects but was associated in male subjects. The inﬂu-
ence of SGA on glucose regulation in young adults with
VLBW might be stronger in males than in females. It is
Figure 2 The gender differences
of glucose and insulin levels
during oral glucose tolerance test
(OGTT) in young adults with very
low birth weight. The top and
bottom of the box indicate lower
and upper quartiles; the line inside
the box represents the median;
the whiskers indicate the most
extreme data points within 1.5
times of IQR from the box; dots
indicate outliers. Male subjects
had signiﬁcantly higher levels of
glucose and lower levels of insulin
during OGTT than female subjects
(p<0.001 for glucose and p¼0.005
for insulin by repeated measures
analysis of variance).
Table 3 Gender differences in glucose regulation in young adults with very low birth weight
Men (n[42) Women (n[69) p Value
Hyperglycaemia 11 (26.2) 10 (14.5) 0.127
Diabetes 0 1
IGT 2 4
IFG 1 0
Non-diabetes/IGT/IFG with
elevated 1 h glucose levels*
85
HbA1c (%) 5.39 (5.31 to 5.47) 5.39 (5.31 to 5.47) 0.635
HOMA-b 72.5 (59.0 to 86.0) 103 (87.2 to 119.6) 0.001
HOMA-IR 1.4 (1.14 to 1.69) 1.6 (1.29 to 1.90) 0.477
Variable during OGTT
Insulinogenic index 1.1 (0.64 to 1.60) 1.4 (1.18 to 1.71) 0.002
GlucoseAUC (mmol/l 3 h) 18.8 (17.9 to 19.7) 18.2 (17.3 to 19.0) 0.089
InsulinAUC (mU/ml 3 h) 135.3 (98.7 to 171.9) 145.1 (121.7 to 168.6) 0.052
Reactive hypoglycaemia 17 (40) 17 (25) 0.079
*Deﬁned as 1 h glucose levels >8.6 mmol/l.
HbA1c, haemoglobin A1c; HOMA-IR, homeostasis model of assessment for insulin resistance; HOMA-b, homeostasis model of assessment for
beta cell; IFG, impaired fasting glycaemia; IGT, impaired glucose tolerance; OGTT, oral glucose tolerance test.
Data are expressed as mean (95% CI) or n (%).
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is owing to the gender difference in the strength of SGA
effect.
Strength and weakness of the study
The major strength of our study is a well-characterised
cohort of subjects with VLBW, who are quite rare in the
general population (approximately 0.5% in this gener-
ation).
31 Our study includes a relatively large number of
young adults with VLBW, and the individuals with
profound complications were carefully excluded in the
recruiting process. In addition, as participants in the
cohort were all Japanese, their racial homogeneity made
considerations of ethnic differences in glucose regula-
tion unnecessary. To date, the glucose regulation of
Asian young adults with VLBW has been uncertain. Our
ﬁndings would be useful to clinicians and researchers
and stimulate future large-scale prospective cohort
studies in Asian populations.
In the present study, we could not obtain information
regarding the growth rate in childhood of all partici-
pants. This is a major limitation of the study. The post-
natal growth pattern in infancy has been shown to be
associated with later glucose intolerance.
32e35 The clin-
ical records of participants were written 20e30 years ago,
and some of them were no longer preserved. Addition-
ally, maternal factors such as advanced age, smoking,
gestational diabetes, and perinatal complications were
not available in the present study. These factors might
have affected fetal malnutrition and subsequently led to
VLBW. In terms of subjects in the present study, our
study has no control subjects, presenting a limitation of
demonstrating the impact of VLBW itself on glucose
regulation. Another concern of the study is selection
bias. Of 301 VLBW subjects who were thought to receive
the invitation letters, 111 subjects (37%) participated in
the study. The ﬁndings should be carefully interpreted
taking into account the possibility that the participants
might not be representative of general young adults with
VLBW.
Future perspective
As neonatal intensive care is making steady progress, an
increasing number of young adults with VLBW world-
wide will face a greater variety of health problems.
Clinician should be aware of the risk of hyperglycaemia
in young adults with VLBW and follow-up them for
a longer period of time. It may be worthwhile for them
to check their glucose metabolism with OGTT in their
20s or 30s, which would lead to early intervention in
their lifestyle and subsequently contribute to prevention
of type 2 diabetes and cardiovascular disease.
5e7 In the
present study, we have found that male gender was
a signiﬁcant independent risk factor of hyperglycaemia
in young adults with VLBW. In addition to the gender
difference, future studies are required to focus on the
factors affecting the glucose metabolism in VLBW
infants.
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